QQ客服 官方微博 反馈留言

	Inhibition of COX-2 and EGFR by Melafolone Improves Anti-PD-1 Therapy through Vascular Normalization and PD-L1 Downregulation in Lung Cancer
	Tang, Honglin; Liu, Yanzhuo; Wang, Chenlong; Zheng, Hao; Chen, Yaxin; Liu, Wen; Chen, Xuewei; Zhang, Jing; Chen, Honglei; Yang, Yuqing
刊名	JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
	2019
卷号	368期号:3
ISSN号	0022-3565
DOI	10.1124/jpet.118.254359
URL标识	查看原文
收录类别	SCIE
语种	英语
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/4263292
专题	武汉大学
推荐引用方式 GB/T 7714	Tang, Honglin,Liu, Yanzhuo,Wang, Chenlong,et al. Inhibition of COX-2 and EGFR by Melafolone Improves Anti-PD-1 Therapy through Vascular Normalization and PD-L1 Downregulation in Lung Cancer[J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS,2019,368(3).
APA	Tang, Honglin.,Liu, Yanzhuo.,Wang, Chenlong.,Zheng, Hao.,Chen, Yaxin.,...&Yang, Jing.(2019).Inhibition of COX-2 and EGFR by Melafolone Improves Anti-PD-1 Therapy through Vascular Normalization and PD-L1 Downregulation in Lung Cancer.JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS,368(3).
MLA	Tang, Honglin,et al."Inhibition of COX-2 and EGFR by Melafolone Improves Anti-PD-1 Therapy through Vascular Normalization and PD-L1 Downregulation in Lung Cancer".JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS 368.3(2019).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。